A股異動丨納思達(002180.SZ)高開超5% 大基金二期15億元領投其子公司
格隆匯12月8日丨納思達(002180.SZ)高開超5%,報32.94元,股價創近3個月新高,總市值350億元。

納思達昨晚公告稱,公司全資子公司艾派克微電子擬以增資擴股及納思達轉讓艾派克股權的方式引入戰略投資者,領投方為國家集成電路產業投資基金二期股份有限公司。
公告顯示,此次艾派克引入的資金將合計32億元。以增資方式獲得股權的投資人,包括大基金二期、珠海格力金融投資管理有限公司、三峽金石(武漢)股權投資基金合夥企業(有限合夥)、珠海橫琴金投創業投資基金合夥企業(有限合夥),其中大基金二期的增資額為15億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.